期刊文献+

临床药师在食道癌患者中的药学监护 被引量:4

Pharmaceutical care for patients with esophageal carcinoma from clinical pharmacist
下载PDF
导出
摘要 目的通过临床药师对食道癌患者的药学监护,促进食道癌患者药物治疗的合理规范。方法临床药师主要从规范化疗方案的选择、关注药物不良反应、用药细节等方面入手,对多例食道癌患者开展药学监护。结果临床药师对化疗方案的选择、不良反应的防治、抗肿瘤药物的给药次序、溶媒的选择、抗菌药物的选用等方面与医师共同制定方案,患者顺利完成化疗。结论临床药师通过对食道癌患者的药学监护,可协助医师更合理的选择用药方案,及早发现并防治药物不良反应的发生,为保证合理有效的用药起到积极的作用。 Objective To improve the rationality in the medication by pharmaceutical care for patients with esophageal carcinoma.Methods Pharmaceutical care was offered for patients with esophageal carcinoma with intervention such as choice of medication,adverse reaction,and details of taking medication.Results Clinical pharmacists assisted doctors in constituting the scheme of chemotherapy,prevention and treatment of adverse reactions,sequence of administration,choice of vehicle and antibiotics,resulting in successful completion of therapy in patients.Conclusion Pharmaceutical care provided by clinical pharmacists may help doctors to choose more reasonable dosage regimen,avoid adverse reactions and play an active role in the rationality and effectiveness of medication.
出处 《中南药学》 CAS 2011年第9期710-712,共3页 Central South Pharmacy
关键词 食道癌 药学监护 化疗方案 不良反应 esophageal carcinoma pharmaceutical care chemotherapy adverse reaction
  • 相关文献

参考文献3

二级参考文献25

  • 1白春梅,徐光勋,赵永强,韩少梅,单渊东.重组人血小板生成素治疗实体肿瘤患者化疗后血小板减少的多中心临床试验[J].中国医学科学院学报,2004,26(4):437-441. 被引量:37
  • 2崔守信.中性粒细胞减少症的治疗进展[J].国外医学(儿科学分册),1995,22(4):175-178. 被引量:6
  • 3Khan S, Dhadda A, Fyfe D, et al. Impact of neutropenia on delivering planned chemotherapy for solid tumors[J]. EurJcanccare, 2008, 17 (1):19.
  • 4Dale DC. Colony - stimulating factors for the management of neutropenia in cancer patients [J].Drugs, 2002, 62 ( Suppl 1 ) : 1.
  • 5Kuderer NM, Dale DC, Crawford J, et al. Impact of primary prophylaxis with granulocyte colony - stimulating factor on febrile neutroperfia and mortality in adult cancer patients receiving chemotherapy : A systematic review [ J ]. J Clin Oncol, 2007, 25 : 3158.
  • 6Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony - stimulating factor in severe chemotherapy- induced afebrile neutropenia [J]. New Eng J Med, 1997, 336 (25): 1776.
  • 7Gay AN, Chang S, Rutland L, et alo Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells : Implications for disease - free survival of high - risk patients[J]. J Pediatr Surg, 2008, 43 (5):837.
  • 8Ludwig H, Van Belle S, Barrett -Lee P, et al. The European Cancer Anaemia Survey (ECAS) : A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients [J]. Eur J Cancer, 2004, 40 : 2293.
  • 9Bohlius, J, Wilson, J, Seidenfeld, J, et al. Recombinant human erythropoietins and cancer patients: Updated meta - analysis of 57 studies including 9353 patients [ J ]. J Natl Cancer Inst, 2006, 98 : 708.
  • 10Maiese K, Li F, Chong Z Z. New avenues of exploration for erythropoietin [J]. JAMA, 2005, 293 ( 1 ) : 90.

共引文献12

同被引文献46

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部